Healthcare Costs Amongst Patients with Non-Small Cell lung cancer (NSCLC) Before and After Testing with a Host Immune Classifier (HIC)

被引：0
|
作者：
Iams, Wade [1 ]
Le, Kimberly [2 ]
Princic, Nicole [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Biodesix Inc, Boulder, CO USA
[3] Merative, Ann Arbor, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.15
引用
收藏
页码：E14 / E14
页数：1
相关论文
共 50 条
  • [41] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Mendis, R.
    McDonald, C. F.
    John, T.
    O'Donoghue, F. J.
    White, S. C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [42] Intrafractional movement of the oesophagus in patients with Non-Small Cell Lung Cancer (NSCLC)
    Panalkis, N.
    McClelland, J.
    Chandler, A.
    Blackall, J.
    Ahmad, S.
    Hughes, S.
    Hawkes, D.
    Landau, D.
    Brada, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 339 - 340
  • [43] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [44] Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
    Zhang, W.
    Yuan, X.
    Wang, X.
    Huang, S.
    Tu, J.
    Liu, F.
    Li, J.
    Li, J.
    Chen, Y.
    Chu, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S132 - S132
  • [45] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [46] Surgery in patients with non-small cell lung cancer (NSCLC):: An analysis of 133 patients
    Skricková, J
    Babicková, L
    Kaplanová, J
    Kubová, O
    Pálková, I
    Tomísková, M
    Svobodník, A
    Spelda, S
    Koptíková, J
    Merta, Z
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 169 - 173
  • [47] Maintenance chemotherapy after frontline therapy in patients with nonsquamous non-small cell lung cancer (NSCLC)
    Santos, E. S.
    Belalcazar, A.
    Gomez, J. E.
    Ochoa, R. E.
    Karr, M.
    Raez, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Chronic immune checkpoint inhibitor (ICI) pneumonitis in patients (pts) with non-small cell lung cancer (NSCLC).
    Stuart, Jessica
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Nishino, Mizuki
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Immune Checkpoint Inhibition for Non-Small Cell Lung Cancer (NSCLC) in Patients with Pulmonary Tuberculosis or Hepatitis B
    Chan, G.
    Huang, Y. Q.
    Ang, Y.
    Chong, W. Q.
    Muthu, V.
    Wong, A.
    Soo, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S722 - S722
  • [50] PREDICTIVE SOLUBLE BIOMARKERS OF IMMUNE RESPONSE TO CHECKPOINT BLOCKADE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Raza, Afsheen
    Mohsen, Reyad
    Kanbour, Aladdin
    Gul, Abdul Rehman Zar
    Philip, Anite
    Vijayakumar, Suma
    Hydrose, Shereena
    Merhi, Maysaloun
    Inchakalody, Varghese
    Uddin, Shahab
    Al Homsi, Mohammed Ussama
    Dermime, Said
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A19 - A19
12345